Section 26B-1-310 - Qualified Patient Enterprise Fund - Creation - Revenue neutrality - Uniform fee(1) There is created an enterprise fund known as the "Qualified Patient Enterprise Fund."(2) The fund created in this section is funded from:(a) money the department deposits into the fund under Chapter 4, Part 2, Cannabinoid Research and Medical Cannabis;(b) appropriations the Legislature makes to the fund; and(c) the interest described in Subsection (3).(3) Interest earned on the fund shall be deposited into the fund.(4) Money deposited into the fund may only be used by:(a) the department to accomplish the department's responsibilities described in Chapter 4, Part 2, Cannabinoid Research and Medical Cannabis; and(b) the Center for Medical Cannabis Research created in Section 53B-17-1402 to accomplish the Center for Medical Cannabis Research's responsibilities.(5) The department shall set fees authorized under Chapter 4, Part 2, Cannabinoid Research and Medical Cannabis in amounts that the department anticipates are necessary, in total, to cover the department's cost to implement Chapter 4, Part 2, Cannabinoid Research and Medical Cannabis.(6) The department may impose a uniform fee on each medical cannabis transaction in a medical cannabis pharmacy in an amount that, subject to Subsection (5), the department sets in accordance with Section 63J-1-504.Amended by Chapter 273, 2023 General Session ,§ 35, eff. 7/1/2023.Renumbered from § 26-61a-109 and amended by Chapter 305, 2023 General Session ,§ 32, eff. 5/3/2023.Amended by Chapter 305, 2023 General Session ,§ 278, eff. 5/3/2023, coordination clause. .Amended by Chapter 281, 2023 General Session ,§ 2, eff. 5/3/2023.Amended by Chapter 5, 2019SP1 General Session ,§ 23, eff. 9/23/2019.Renumbered from §26-60b-109 and amended by Chapter 1, 2018SP3 General Session ,§ 53, eff. 12/3/2018.Added by Utah Proposition 2, Medical Marijuana Initiative (2018), approved by the voters at the general election held on 11/6/2018, and effective 12/1/2018.